Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis

2007; Oxford University Press; Volume: 59; Issue: 4 Linguagem: Inglês

10.1093/jac/dkl552

ISSN

1460-2091

Autores

Esteban Ribera, Carlos Azuaje, Rosa María López, Peré Domingo, Adrián Curran, Maria Feijoo‐Cid, Leonor Pou, Paquita Sánchez, M. A. Sambeat, J Colomer, Josep Lluis Lopez-Colomes, Manuel Crespo, Vicenç Falcó, I Ocaña, Albert Pahissa,

Tópico(s)

Pneumocystis jirovecii pneumonia detection and treatment

Resumo

ObjectivesTo assess plasma steady-state pharmacokinetics (PK) of rifampicin, isoniazid, saquinavir and ritonavir in HIV and tuberculosis (TB) co-infected patients, and investigate potential interactions between TB drugs and protease inhibitors (PIs).

Referência(s)